Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29576624

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2018 May
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Motzer RJ
      type
      Author
    2. name
      Escudier B
      type
      Author
    3. name
      Powles T
      type
      Author
    4. name
      Scheffold C
      type
      Author
    5. name
      Choueiri TK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Motzer RJ
      type
      Author
    2. name
      Escudier B
      type
      Author
    3. name
      Powles T
      type
      Author
    4. name
      Scheffold C
      type
      Author
    5. name
      Choueiri TK
      type
      Author
    bibliography ids
    1. nci-bib-fe057a3890f2e04925a707c2
    book metadata
    content sha256
    f91d2e3f19543d382a0282b59b7b3ed2dbc2eaae10d1cfc27a64e55582752f3d
    document type
    citation
    dois
    1. 10.1038/s41416-018-0061-6
    electronic publication date
    display
    2018 Mar 26
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29576624
    immutable id
    pubmed:29576624@f91d2e3f19543d382a0282b59b7b3ed2dbc2eaae10d1cfc27a64e55582752f3d
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    9
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    1176-1178
    volume
    118
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29576624
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      234a3833e4624f9bd05f1a23e2da9f40550b4e1939ce3ec6340e1ae44c96dbf3
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 May
      precision
      month
      year
      2018
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29576624/
      title
      Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.

      Preserved source evidence · Not medical advice